Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-11 5:25 pm Sale |
2020-12-31 | 13G | Calithera Biosciences, Inc. CALA |
BIOTECHNOLOGY VALUE FUND L P | 218,062 6.200% |
-136,470 (-38.49%) |
Filing History |
| 2021-02-11 5:23 pm Sale |
2020-12-31 | 13G | Molecular Templates, Inc. MTEM |
BIOTECHNOLOGY VALUE FUND L P | 184,075 5.500% |
-56,481 (-23.48%) |
Filing History |
| 2021-02-11 5:20 pm Purchase |
2020-12-31 | 13G | ESSA Pharma Inc. EPIX |
BIOTECHNOLOGY VALUE FUND L P | 3,705,289 11.000% |
1,064,724 (+40.32%) |
Filing History |
| 2021-02-11 5:18 pm Sale |
2020-12-31 | 13G | Forward Pharma A/S FWPAY |
BIOTECHNOLOGY VALUE FUND L P | 35,771 10.700% |
-13,677 (-27.66%) |
Filing History |
| 2021-02-11 5:16 pm Sale |
2020-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
BIOTECHNOLOGY VALUE FUND L P | 50 1.000% |
-3,079,105 (-100.00%) |
Filing History |
| 2021-02-11 5:14 pm Purchase |
2020-12-31 | 13G | GlycoMimetics, Inc. GLYC |
BIOTECHNOLOGY VALUE FUND L P | 9,544,262 19.960% |
2,182,461 (+29.65%) |
Filing History |
| 2021-02-11 5:12 pm Sale |
2020-12-31 | 13G | Replimune Group, Inc. REPL |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,309,109 (Position Closed) |
Filing History |
| 2021-02-11 5:10 pm Sale |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,125,650 (Position Closed) |
Filing History |
| 2021-02-11 5:08 pm Sale |
2020-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-3,755,553 (Position Closed) |
Filing History |
| 2021-02-11 5:06 pm Purchase |
2020-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 3,226,769 11.100% |
2,597 (+0.08%) |
Filing History |
| 2021-02-11 4:59 pm Sale |
2020-12-31 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 1,245,912 1.900% |
-1,188,784 (-48.83%) |
Filing History |
| 2021-02-11 4:52 pm Purchase |
2020-12-31 | 13G | Cogent Biosciences, Inc. COGT |
BIOTECHNOLOGY VALUE FUND L P | 3,114,250 4.700% |
3,114,250 (New Position) |
Filing History |
| 2021-02-11 4:43 pm Sale |
2020-12-31 | 13G | Curis, Inc. CRIS |
BIOTECHNOLOGY VALUE FUND L P | 31,347 1.000% |
-151,153 (-82.82%) |
Filing History |
| 2021-02-11 4:41 pm Sale |
2020-12-31 | 13G | AnaptysBio, Inc. ANAB |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-1,441,565 (Position Closed) |
Filing History |
| 2021-02-11 4:33 pm Sale |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,740,000 (Position Closed) |
Filing History |
| 2021-02-11 4:30 pm Sale |
2020-12-31 | 13G | Brickell Biotech, Inc. BBI |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-14,757 (Position Closed) |
Filing History |
| 2021-02-11 4:22 pm Purchase |
2020-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 931,750 6.600% |
404,333 (+76.66%) |
Filing History |
| 2021-02-01 5:19 pm Purchase |
2021-01-22 | 13G | FIVE PRIME THERAPEUTICS INC FPRX |
BIOTECHNOLOGY VALUE FUND L P | 3,138,678 7.200% |
1,875,000 (+148.38%) |
Filing History |
| 2021-01-29 4:36 pm Sale |
2021-01-27 | 13D | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 40,819 20.400% |
-3,800 (-8.52%) |
Filing History |
| 2021-01-26 5:26 pm Sale |
2021-01-22 | 13D | Infinity Pharmaceuticals, Inc. INFIQ |
BIOTECHNOLOGY VALUE FUND L P | 10,726,968 16.700% |
-6,700,000 (-38.45%) |
Filing History |